IFP Advisors’s Q32 Bio QTTB Stock Holding History

IFP Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14	Closed	-$221	–	3579
2023 Q2	$221	Buy	+14	New	+$251	﹤0.01%	3309
2020 Q4	–	Sell	-1	Closed	-$193	–	3124
2020 Q3	$0	Buy	+1	New	+$224	﹤0.01%	3028

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

IFP Advisors's QTTB Position: Q3 2023 in Review

IFP Advisors sold out of Q32 Bio (QTTB) in Q3 2023, closing a stake of 14 shares — an estimated $221 sold.

IFP Advisors first reported a position in QTTB in Q3 2020 and held it in 2 quarters. The position peaked at $221 in Q2 2023. 58 funds tracked by Wall St. Rank hold QTTB as of Q3 2023.

IFP Advisors reported no remaining Q32 Bio position as of Q3 2023 after selling out during the quarter.
IFP Advisors sold 14 Q32 Bio shares in Q3 2023, an estimated $221.
IFP Advisors first reported a position in Q32 Bio in Q3 2020 and held it in 2 quarters.
IFP Advisors's Q32 Bio position peaked at $221 in Q2 2023.
58 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2023.

Based on IFP Advisors's 13F filing for Q3 2023, filed 12 Oct 2023.